肝素结合血凝素作为结核疫苗组分抗原通过诱导IL-17发挥保护性免疫效应
研究以6~8周龄雌性C57BL/6小鼠为对象,比较HBHA滴鼻、ESAT-6滴鼻及BCG初免HBHA加强等策略的免疫效应;结果显示BCG初免HBHA加强组血浆IL-17A与肺IL-17A mRNA最高,脾Th17比例升高,并促进肺三级淋巴结构形成、感染早期降低肺细菌负荷。
要点
- BCG初免HBHA加强组血浆IL-17A为(14.76±4.73)pg/mL,高于对照组和BCG初免PBS对照组。
- BCG初免HBHA加强组脾Th17比例为(1.02±0.34)%,高于BCG初免PBS对照组的(0.38±0.38)%。
- HBHA加强促进肺部三级淋巴结构形成,并在BCG攻击感染早期降低肺细菌负荷。
核心结论
- 黏膜递送HBHA可有效增强BCG接种后的免疫保护效应,可能是一种有潜力的候选疫苗组分。
研究设计与样本
- 动物实验使用6~8周龄雌性C57BL/6小鼠,30只小鼠随机分为对照组、ESAT-6滴鼻组、HBHA滴鼻组、BCG初免PBS对照组、BCG初免HBHA加强组,每组6只。
- BCG初免PBS对照组和BCG初免HBHA加强组每组各30只小鼠,用BCG滴鼻模拟感染,在感染后预设时间点做肺组织菌落计数以评估细菌清除效率。
主要发现
- BCG初免HBHA加强组血浆IL-17A为(14.76±4.73)pg/mL,高于对照组的(5.57±2.95)pg/mL(t=4.213,P<0.001),也高于BCG初免PBS对照组的(6.81±2.18)pg/mL(t=3.646,P=0.001)。
- BCG初免HBHA加强组肺IL-17A mRNA相对表达量为(12.27±6.71),高于对照组的(1.30±0.97)(t=5.984,P<0.001),也高于BCG初免PBS对照组的(1.44±1.16)(t=6.185,P<0.001)。
- BCG初免HBHA加强组脾Th17细胞比例为(1.02±0.34)%,高于BCG初免PBS对照组的(0.38±0.38)%(t=-0.280,P=0.048)。
- HBHA加强可促进肺部三级淋巴结构形成,并在BCG攻击感染早期降低肺细菌负荷。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
To explore the protective immune effect induced by mucosal delivery heparin-binding hemagglutinin (HBHA)-a candidate vaccine antigen of Mycobacterium tuberculosis. Female C57BL/6 mice were between 6 and 8 weeks of age before experimental use. Thirty mice received different immunization strategies and were randomly divided into the control group, the early secreting antigen target-6 (ESAT-6) intranasal immunization group, the HBHA intranasal immunization group, the BCG priming PBS control group, or BCG priming HBHA boost group, 6 mice in each group. In order to analyzed the immune effect, the concentrations of plasma Interleukin-17A (IL-17A) and other cytokines were measured by ELISA. Quantitative real-time PCR analyses were performed to detect the relative quantity (RQ) mRNA of IL-17A in the lung. The lung tissue sections were stained to detect the formation of the tertiary lymphoid structures. The chemokines contributed to formation of the tertiary lymphoid structures were also measured. Flow cytometry was used to detect the frequency of Th1 and Th17 cells in the system. Sixty mice in the BCG priming PBS control group and the BCG priming HBHA boost group were sacrificed at different time points after infection to count the lung bacterial burden. The concentrations of plasma IL-17A and relative quantity of lung IL-17A mRNA were highest in the BCG priming HBHA boost group [(14.76±4.73) pg/mL,RQ (12.27±6.71)], which was significantly higher than the control group [(5.57±2.95) pg/mL,RQ (1.30±0.97)] (t=4.213, P<0.001; t=5.984, P<0.001), and also significantly higher than the BCG priming PBS control group [(6.81±2.18) pg/mL,RQ (1.44±1.16)] (t=3.646 P=0.001; t=6.185 P<0.001). Compared with the BCG priming PBS control group (0.38±0.38)% the frequency of spleen Th17 cells were also significantly increased (t=-0.280, P=0.048) in the BCG-primary HBHA boost group (1.02±0.34)%. In addition, HBHA boosting could promote better formation of the tertiary lymphoid structures in the lung, and decrease the bacterial load on the early stage after BCG challenge. Collectively, mucosal delivery of HBHA can effectively enhance the protective effect after BCG vaccination, and it is a potential candidate vaccine component. 为探讨疫苗候选抗原—结核分枝杆菌肝素结合血凝素(HBHA)通过黏膜接种诱导的保护性免疫效应。动物实验均使用6~8周龄雌性C57BL/6小鼠。30只小鼠接受不同的免疫接种策略,采用随机数字表法分为对照组、早期分泌抗原靶蛋白-6(ESAT-6)滴鼻组、HBHA滴鼻组、BCG初免PBS对照组、BCG初免HBHA加强组,每组6只。通过检测免疫后小鼠血浆白细胞介素17A(IL-17A)等细胞因子水平;肺IL-17A mRNA相对表达量(RQ);肺三级淋巴结构的形成,及与其形成相关的趋化因子的检测;脾Th1、Th17细胞比例比较,从而分析免疫效应。BCG初免PBS对照组和BCG初免HBHA加强组(每组各30只小鼠),用BCG滴鼻模拟感染。在感染后预设的时间点做肺组织菌落计数,以评估细菌清除效率。多组间比较采用单因素方差分析,事后分析采用LSD检验;两组间比较采用独立样本t检验。结果显示,免疫后的小鼠血浆细胞因子IL-17A水平和肺IL-17A mRNA相对表达量,在BCG初免HBHA加强组[(14.76±4.73)pg/mL,RQ 为(12.27±6.71)]中最高,比对照组[(5.57±2.95)pg/mL,RQ为(1.30±0.97)]明显升高(t=4.213,P<0.001;t=5.984,P<0.001),也显著高于BCG初免PBS对照组[(6.81±2.18)pg/mL,RQ 为(1.44±1.16)](t=3.646 P=0.001;t=6.185 P<0.001)。脾脏Th17细胞比例,与BCG初免PBS对照组(0.38±0.38)%比较,BCG初免HBHA加强组(1.02±0.34)%显著增高(t=-0.280,P=0.048),该组在肺部诱导形成了三级淋巴结构,并在感染的早期降低了肺细菌负荷。综上,HBHA通过黏膜递送可有效增强BCG接种后的免疫保护效应,可能是一种有潜力的候选疫苗组分。.
引用
- Cai Z, Huang Y, Tang JH, et al. [Heparin-binding hemagglutinin as a composition antigen of tuberculosis vaccine exerts protective immune effects by inducing IL-17]. Zhonghua Yu Fang Yi Xue Za Zhi. 2022. PMID: 35381662. doi:10.3760/cma.j.cn112150-20211206-01122
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。